Effectiveness of Stellate Ganglion Block for the Treatment of Obstructive Sleep Apnea - Trial NCT06319612
Access comprehensive clinical trial information for NCT06319612 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Copka Sonpashan
Chao Phya Abhaibhubejhr Hospital
Timeline & Enrollment
N/A
Mar 01, 2024
Dec 01, 2024
Primary Outcome
Epworth Sleepiness Scale
Summary
The goal of this clinical trial is to test the efficacy of stellate ganglion block in
 Obstructive Sleep Apnea. The main question it aims to answer are:
 
 • Can stellate ganglion block improve Obstructive Sleep Apnea? Patients were randomly divided
 into two groups, all provided with routine therapy. Based on this, the experimental group was
 given stellate ganglion block. The video fluoroscopic swallowing study was done to test the
 swallowing function before and after the study.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06319612
Non-Device Trial